Association between umbilical cord glucocorticoids and blood pressure at age 3 years

By Susanna Y. Huh, Ruth Andrew, J. Rich-Edwards, K. Kleinman, J. Seckl, M. W. Gillman. BMC Medicine, 2008

1,276 citations recorded by the source corpus.

BackgroundAnimal data show that decreased activity of placental 11-beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2), which potently inactivates glucocorticoids (e.g. cortisol) to inert forms (cortisone), allows increased access of maternal glucocorticoids to the fetus and 'programs' hypertension. Data in humans are limited. We examined in humans the association between venous umbilical cord blood glucocorticoids, a potential marker for placental 11β-HSD2 enzyme activity, and blood pressure at age 3 years.MethodsAmong 286 newborns in Project Viva, a prospective pre-birth cohort study based in eastern Massachusetts, we measured cortisol (F) and cortisone (E) in venous cord blood and used the ratio of F/E as a marker for placental 11β-HSD2 activity. We measured blood pressure (BP) when the offspring reached age 3 years. Using mixed effects regression models to control for BP measurement conditions, maternal and child characteristics, we examined the association between the F/E ratio and child BP.ResultsAt age 3 years, each unit increase in the F/E ratio was associated with a 1.6 mm Hg increase in systolic BP (95% CI 0.0 to 3.1). The F/E ratio was not associated with diastolic blood pressure or birth weight for gestational age z-score.ConclusionA higher F/E ratio in umbilical venous cord blood, likely reflecting reduced placental 11β-HSD2 activity, was associated with higher systolic blood pressure at age 3 years. Our data suggest that increased fetal exposure to active maternal glucocorticoids may program later systolic blood pressure.

Subfields: Behavioral Neuroscience, Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/f5f17a57980f7d3fc6c3799bcfbc11f271d4fd3a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. T. Cox
2. Andrew M. Handorf
3. J. Bredfeldt
4. Cameron G Walker
5. J. Erler
6. E. Henke
7. Yaxian Zhou
8. Yuming Liu

Citations in the corpus

• Mechanics, malignancy, and metastasis: The force journey of a tumor cell (2009, background): “Rapidly migrating transformed mammary epithelial cells have been observed on these prominent linear bundles of collagen fibers adjacent to blood vessels [35–37].”
• Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance (2019, background): “In breast cancers, collagen I becomes highly linearized, as if it were under tension, and oriented either tangentially or perpendicular to the tumor-stroma interface (Provenzano et al., 2008).”
• A tense situation: forcing tumour progression (2009, background): “Rapidly migrating transformed mammary epithelial cells have been observed on prominent linear bundles of collagen fibres adjacent to blood vessel”
• Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy (2020, background): “Many solid tumors express high levels of various ECMmolecules like fibrillar collagens, fibronectin, elastin, and laminins (Provenzano et al., 2008; Mammoto et al., 2013).”
• Role of Extracellular Matrix in Development and Cancer Progression (2018, background): “It has bee s t at pancreatic tu o r cells are able to induce activation of PSCs through increased secretion of TGF-β a F [141]. r, recent studies have indicated that PS s ay be able to sustain activation e to the echanical properties of the icroenvironment alone [209,210]. ur recent work has shown t”
• The extracellular matrix modulates the hallmarks of cancer (2014, neutral): “The cancer-associated ECM is not only an integral feature of a tumor but also actively contributes to its histopathology and behavior [7,8].”
• Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer (2011, background): “Type I collagen and fibronectin are the most common and abundant ECM components deposited in cancer (Provenzano et al., 2008) as a result of desmoplasia.”
• Engineering microscale topographies to control the cell–substrate interface (2012, background): “For instance, in breast cancer metastasis, collagen fibers that are radiating outward from the mammary glands are known to mediate the directional migration of highly tumorigenic cells into the surrounding tissue [111-113].”
• Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited (2009, background): “…of the tumor cell invasion program proceed through collagen-rich areas whose penetration would appear to be more consistent with the slower advance of proteolytically active neoplastic cell populations (Li et al., 2000; Curino et al., 2005; Provenzano et al., 2006, 2008a; Kedrin et al., 2008).”
• Computational segmentation of collagen fibers from second-harmonic generation images of breast cancer (2014, result): “These descriptions are consistent with previously published observations of common collagen structures in tissues.(7,11,12) In addition, depending on imaging parameters such as depth within the tissue, images can have low signal-to-noise ratio (SNR) and potentially low-dynamic range [Figs.”